HSIC
42
2
O
26
16
ZION
49
9
AAPL
64
3
ETN
64
4
QRVO
16
-6
HRB
40
3
MHK
25
5
GILD
55
5
TROW
37
8
MCO
67
3
CAH
44
7
V
70
14
PVH
58
5
PSX
24
2
SO
48
6
ES
12
3
A
43
2
LOW
42
14
DNB
72
4
HSIC
42
2
O
26
16
ZION
49
9
AAPL
64
3
ETN
64
4
QRVO
16
-6
HRB
40
3
MHK
25
5
GILD
55
5
TROW
37
8
MCO
67
3
CAH
44
7
V
70
14
PVH
58
5
PSX
24
2
SO
48
6
ES
12
3
A
43
2
LOW
42
14
DNB
72
4
Financhill
Back

Catalyst Pharmaceuticals Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55

CPRX
Catalyst Pharmaceuticals

Last Price:
$21.26
Seasonality Move:
6.88%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Catalyst Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 39.8% based on the past 18 years of stock performance.
  • Catalyst Pharmaceuticals has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Catalyst Pharmaceuticals Stock Undervalued?
    The current Catalyst Pharmaceuticals [CPRX] share price is $21.27. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Catalyst Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Catalyst Pharmaceuticals has on average historically risen by 39.8% based on the past 18 years of stock performance.

Catalyst Pharmaceuticals Stock Rating

Buy
55
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals overpriced?

  • Catalyst Pharmaceuticals has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Catalyst Pharmaceuticals Stock Price History

Is CPRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com

52-Week Data

52-Week High:
24.27
52-Week Low:
13.12

Prediction Charts

Market Cap:
2.5B
Price in USD:
21.27
Volume:
1.7M
Beta:
1.09

Technical Analysis

SMA50:
21.71
SMA100:
20.64
SMA200:
18.26
52-Wk Change:
48.74%

Stock Predictions

  • Is Catalyst Pharmaceuticals stock public?
    Yes, Catalyst Pharmaceuticals is a publicly traded company.
  • What is the Catalyst Pharmaceuticals stock quote today?
    The Catalyst Pharmaceuticals stock price is 21.27 USD today.
  • How to buy Catalyst Pharmaceuticals stock online?
    You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 22.52 21.71 22.59 21.50
Dec-4 21.74 21.96 22.06 21.56
Dec-5 21.74 21.70 21.92 21.50
Dec-6 21.83 22.02 22.08 21.79
Dec-9 22.12 21.74 22.35 21.71
Dec-10 21.82 22.11 22.14 21.70
Dec-11 22.11 21.97 22.14 21.58
Dec-12 21.86 21.34 22.03 21.31
Dec-13 21.27 21.38 21.42 20.93
Dec-16 21.43 21.65 22.04 21.33
Dec-17 21.64 22.07 22.49 21.64
Dec-18 22.08 21.35 22.67 21.17
Dec-19 21.62 21.46 21.75 21.11
Dec-20 21.27 21.27 21.41 21.01

Catalyst Pharmaceuticals Earnings

Catalyst Pharmaceuticals Earnings Report: Per Share Catalyst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Catalyst Pharmaceuticals Forecast Revenue Growth

Catalyst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.

* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.